The goal of this clinical trial is to assess third-generation dual-source coronary computed tomography angiography (CCTA) performance in the evaluation of long coronary stents in patients with coronary artery chronic total occlusions. The main questions it aims to answer are: * Can patency of long coronary artery stents be assessed with third generation CCTA? * What are the factors affecting the assessability? * What is the radiation exposure of third generation CCTA?
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Stent patency assesment with third-generation dual-source CCTA
Timeframe: up to 7.3 months (maximum time between CCTA and ICA)